Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07496736 Oseltamivir Phosphate Influenza, Human Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07496736 clinical trial report covering Oseltamivir Phosphate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07496450 mRNA-1018 Influenza, Human Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07496450 clinical trial report covering mRNA-1018, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07497438 Etoposide Lymphohistiocytosis, Hemophagocytic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07497438 clinical trial report covering Etoposide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07495033 Telitacicept Interstitial lung disease due to connective tissue disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07495033 clinical trial report covering Telitacicept, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
TCTR20260327002 Tranexamic Acid Melanosis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
TCTR20260327002 clinical trial report covering Tranexamic Acid, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07496372 iPSC derived cardiac muscle cell (Help Therapeutics) Heart Failure Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07496372 clinical trial report covering iPSC derived cardiac muscle cell (Help Therapeutics), Phase 3, endpoints, sponsor, geography, readout timing and
Latest Hotspot
8 min read
NCT07498426 NI-O752 Supranuclear Palsy, Progressive Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07498426 clinical trial report covering NI-O752, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07498335 Atrasentan Hydrochloride Glomerulonephritis, IGA Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07498335 clinical trial report covering Atrasentan Hydrochloride, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07497087 Nerandomilast CREST Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07497087 clinical trial report covering Nerandomilast, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07499817 Pentoxifylline Infertility Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07499817 clinical trial report covering Pentoxifylline, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07500207 Rabies vaccine (Changchun BCHT ) Rabies Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07500207 clinical trial report covering Rabies vaccine (Changchun BCHT ), Phase 3, endpoints, sponsor, geography, readout timing and development white s
Latest Hotspot
8 min read
NCT07500090 Pitolisant Hydrochloride Idiopathic Hypersomnia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07500090 clinical trial report covering Pitolisant Hydrochloride, Phase 3, endpoints, sponsor, geography, readout timing and development white space.